Current approach to fibrous dysplasia of bone and McCune-Albright syndrome
- PMID: 19308500
- PMCID: PMC2656698
- DOI: 10.1007/s11832-007-0006-8
Current approach to fibrous dysplasia of bone and McCune-Albright syndrome
Abstract
Fibrous dysplasia (FD) of bone is an uncommon disease caused by sporadic, congenital mutations in the cAMP regulating protein, G(s)alpha. It is an example of somatic mosaicism in which a wide spectrum of disease is possible. Widespread skeletal involvement is often associated with varying combinations of café-au-lait skin spots, and/or endocrine dysfunction (precocious puberty, renal phosphate wasting, hyperthyroidism, and/or growth hormone excess). Unrecognized and untreated endocrine dysfunction can exacerbate the skeletal disease. The diagnosis is usually established on clinical grounds on the basis of physical examination and typical radiographic appearance. Occasionally, gene testing of affected tissue may be helpful. The skeletal sites involved with disease are established at an early age, and the complications of fracture deformity are most pronounced in childhood. Bone pain in the absence of a fracture is more common in adults, but can also be present in children. Treatment with bisphosphonates is usually effective at relieving pain, but probably has no effect on the natural history of the disease. Scoliosis, which was previously thought to be an uncommon occurrence, has been shown to be common and progressive, and as such, warrants investigation and, when necessary, surgical treatment. The surgical management of FD remains challenging. Timing and technique remain controversial, but some consensus exists in that grafting materials (of any type) usually fail and should not be a central aspect of the surgical approach. Intramedullary devices are in general superior to side plates and screws. In extremely widespread disease with very early fracture and deformity, no surgical approach will affect final functional outcome. Efforts should be made for the initiation of international collaborative studies to better define optimal surgical approaches to the treatment of this challenging disease.
Figures










Similar articles
-
McCune-Albright syndrome.Orphanet J Rare Dis. 2008 May 19;3:12. doi: 10.1186/1750-1172-3-12. Orphanet J Rare Dis. 2008. PMID: 18489744 Free PMC article.
-
Fibrous Dysplasia / McCune-Albright Syndrome.2015 Feb 26 [updated 2024 Feb 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2015 Feb 26 [updated 2024 Feb 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 25719192 Free Books & Documents. Review.
-
McCune-Albright syndrome: clinical picture and natural history in children and adolescents.J Pediatr Endocrinol Metab. 2006 May;19 Suppl 2:551-9. doi: 10.1515/jpem.2006.19.s2.551. J Pediatr Endocrinol Metab. 2006. PMID: 16789617 Review.
-
[McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].Ann Dermatol Venereol. 2016 Jan;143(1):21-6. doi: 10.1016/j.annder.2015.10.585. Epub 2015 Nov 25. Ann Dermatol Venereol. 2016. PMID: 26610360 French.
-
Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.Front Endocrinol (Lausanne). 2018 Mar 15;9:96. doi: 10.3389/fendo.2018.00096. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29599748 Free PMC article.
Cited by
-
Fibrous dysplasia for radiologists: beyond ground glass bone matrix.Insights Imaging. 2018 Dec;9(6):1035-1056. doi: 10.1007/s13244-018-0666-6. Epub 2018 Nov 27. Insights Imaging. 2018. PMID: 30484079 Free PMC article. Review.
-
Eight-year follow-up of a girl with McCune-Albright syndrome.J Clin Res Pediatr Endocrinol. 2011;3(1):40-2. doi: 10.4274/jcrpe.v3i1.09. Epub 2011 Feb 23. J Clin Res Pediatr Endocrinol. 2011. PMID: 21448334 Free PMC article.
-
Individualized approach to the surgical management of fibrous dysplasia of the proximal femur.Orphanet J Rare Dis. 2018 May 2;13(1):72. doi: 10.1186/s13023-018-0805-7. Orphanet J Rare Dis. 2018. PMID: 29720212 Free PMC article.
-
Osteodystrophies of jaws.J Oral Maxillofac Pathol. 2020 May-Aug;24(2):405. doi: 10.4103/jomfp.JOMFP_225_19. Epub 2020 Sep 9. J Oral Maxillofac Pathol. 2020. PMID: 33456267 Free PMC article. Review.
-
A Rare Skeletal Disorder, Fibrous Dysplasia: A Review of Its Pathogenesis and Therapeutic Prospects.Int J Mol Sci. 2023 Oct 26;24(21):15591. doi: 10.3390/ijms242115591. Int J Mol Sci. 2023. PMID: 37958575 Free PMC article. Review.
References
-
- McCune DJ. Osteitis fibrosa cystica: the case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child. 1936;52:743–744.
-
- Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas, of pigmentation, and endocrine dysfunction, with precocious puberty in females: report of 5 cases. N Engl J Med. 1937;216:727–746. doi: 10.1056/NEJM193704292161701. - DOI
-
- Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg. 1938;36:874–898. doi: 10.1001/archsurg.1938.01190230153012. - DOI
-
- Lichtenstein L, Jaffe HL. Fibrous dysplasia of bone: a condition affecting one, several or many bones, graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Pathol. 1942;33:777–816.
-
- Dorfman HD, Czerniak B (1998) Fibroosseous lesions. In: Dorfman HD, Czerniak B (eds) Bone tumors. Mosby, St. Louis, pp 441–491
LinkOut - more resources
Full Text Sources